Crowdonomics
This isn’t Regen BioPharma Inc’s most recent raise. Reg A+ · Equity · Dec 2025 (Open) is more current.View latest round
Regen BioPharma Inc

Section 4(a)(2) · Series A Preferred Shares · Feb 2018

ClosedOtherPreferred Equity
via the platform · last checked Oct 7, 2026
Raised
$25K
Investors
—
—
Estimated pre-money
$3.2M
—

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Deal terms

Est. pre-money$3.2M
Price / share$0.01
Price / share today$15.00

Estimated, not stated: $0.01 × 321,197,496 securities outstanding as of Dec 31, 2017 (Form 10-Q filed Feb 6, 2018, p. 1).

$0.01 as sold; $15.00 after the Mar 2023 split (1:1500) (Form 10-Q, p. 1).

Down round. Priced 60% below Section 4(a)(2) Private Offering (2016) (Nov 2016) on a split-adjusted basis: $15.00 vs $37.50 a share in today's terms.

Offering details

Target—
Max—
Min investment—
OpenedFeb 5, 2018
Deadline—
ClosedFeb 5, 2018
Days active1

Links & provenance

Source: SEC EDGAR
Last synced Oct 7, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.